Market by Deployment Mode, Component, Product Type, End-user, and Country | Forecast 2021-2028
Triton’s
report suggests that the North America clinical trial management market is
forecasted to grow at a CAGR of 10.39% during the projected period 2021-2028.
Report scope can be customized per your requirements. Request For Customization
The
countries studied in this market are:
• United States
• Canada
In
the region, the demand for clinical trial management has observed substantial
growth, owing to the well-developed healthcare infrastructure. Moreover,
several clinical trials are undertaken in the US and Canada, adding to the
reviewed market’s progress. Above all, the presence of prominent pharmaceutical
companies, along with the growing awareness pertaining to the advantages of CTM
systems, is another set of factors motivating the clinical trial management
market’s growth across North America.
In
the region, the United States has been at the forefront of clinical research
for several years. Moreover, the country has the highest concentration of
contract research organizations, including Parexel International Corp and
Laboratory Corp of America Holdings. Here, the presence of prominent market
players, coupled with strict FDA regulations, indicates the market to be quite
competitive across the nation. Further, IRB is an independent committee that
ensures that clinical trials conducted are ethical and the study participants’
rights are protected. All institutes that support or carry out biomedical
research are mandated by the federal regulation to have IRB approve and
regularly review the study. This frequent regulation increases the demand for
effective clinical trial management products, further driving the clinical
trial management market’s growth.
In
Canada, the rapid increase in decentralization has expanded the scope of
testing beyond the conventional laboratory environment. This has encouraged
several players to enter this segment. Additionally, the Ministry of Health’s
increase in funding has helped the clinical laboratory sector grow
significantly across the country. Such developments are likely to boost the
demand for clinical trial management.
Veeva
Systems Inc is engaged in offering cloud solutions for the life science
industry. The company provides numerous solutions, including clinical,
regulatory, quality, medical, and commercial solutions. Veeva vault clinical
suite is the first cloud platform that merges CDMS, CTMS, and study startup to
deliver a highly inclusive clinical cloud application suite. Founded in 2007,
the company is headquartered in the United States.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. NORTH
AMERICA CLINICAL TRIAL MANAGEMENT MARKET - SUMMARY
2. INDUSTRY
OUTLOOK
2.1. MARKET
SCOPE
2.2. KEY
INSIGHTS
2.2.1. ENTERPRISE-BASED
CTM CONTRIBUTES A MAJOR SHARE IN PRODUCT TYPE SEGMENT
2.2.2. HEALTHCARE
PROVIDERS ARE RAPIDLY GROWING END-USERS IN THE MARKET
2.2.3. SOFTWARE
IS THE LARGEST COMPONENT IN THE CLINICAL TRIAL MANAGEMENT MARKET
2.2.4. CLOUD
MODEL OF DEPLOYMENT IS A PROMISING SEGMENT IN THE MARKET
2.3. PORTER’S
FIVE FORCES ANALYSIS
2.3.1. THREAT
OF NEW ENTRANTS
2.3.2. THREAT
OF SUBSTITUTE
2.3.3. BARGAINING
POWER OF SUPPLIERS
2.3.4. BARGAINING
POWER OF BUYERS
2.3.5. INTENSITY
OF COMPETITIVE RIVALRY
2.4. MARKET
ATTRACTIVENESS INDEX
2.5. VENDOR
SCORECARD
2.6. MARKET
DRIVERS
2.6.1. ALARMING
RISE IN CHRONIC DISEASES
2.6.2. SURGE
IN RESEARCH & DEVELOPMENT IN THE MEDICAL SECTOR
2.6.3. BENEFITS
OFFERED BY CTM SOFTWARE
2.7. MARKET
RESTRAINTS
2.7.1. CONCERN
REGARDING THE SECURITY OF CTM SYSTEMS
2.7.2. LACK
OF SKILLED WORKFORCE
2.7.3. HIGH
COST OF IMPLEMENTATION
2.8. MARKET
OPPORTUNITIES
2.8.1. GROWTH
IN CLINICAL TRIALS
2.8.2. OUTSOURCING
CLINICAL TRIALS FOR COST REDUCTION
2.9. KEY
STRATEGIC DEVELOPMENTS
2.9.1. MERGER
& ACQUISITIONS
2.9.2. PRODUCT
LAUNCH & DEVELOPMENTS
2.9.3. PARTNERSHIP,
CONTRACT/AGREEMENT, & COLLABORATION
2.10. IMPACT
OF COVID-19 ON THE CLINICAL TRIAL MANAGEMENT MARKET
3. NORTH
AMERICA CLINICAL TRIAL MANAGEMENT MARKET OUTLOOK - BY DEPLOYMENT MODE
3.1. WEB-BASED
DEPLOYMENT
3.2. ON-PREMISE
DEPLOYMENT
3.3. CLOUD-BASED
DEPLOYMENT
4. NORTH
AMERICA CLINICAL TRIAL MANAGEMENT MARKET OUTLOOK - BY COMPONENT
4.1. SOFTWARE
4.2. HARDWARE
4.3. SERVICES
5. NORTH
AMERICA CLINICAL TRIAL MANAGEMENT MARKET OUTLOOK - BY PRODUCT TYPE
5.1. ENTERPRISE-BASED
CTM
5.2. SITE-BASED
CTM
6. NORTH
AMERICA CLINICAL TRIAL MANAGEMENT MARKET OUTLOOK - BY END-USER
6.1. PHARMACEUTICAL
& BIOPHARMACEUTICAL COMPANIES
6.2. CLINICAL
RESEARCH ORGANIZATIONS
6.3. HEALTHCARE
PROVIDERS
7. CLINICAL
TRIAL MANAGEMENT MARKET – NORTH AMERICA
7.1. UNITED
STATES
7.2. CANADA
8. COMPETITIVE
LANDSCAPE
8.1. MEDIDATA
SOLUTIONS INC
8.2. ARISGLOBAL
LLC
8.3. BIOCLINICA
INC
8.4. BIO-OPTRONICS
INC
8.5. ADVARRA
(FORTE RESEARCH SYSTEMS INC)
8.6. ORACLE
CORPORATION
8.7. IBM
CORPORATION
8.8. MEDNET
SOLUTIONS INC
8.9. PAREXEL
INTERNATIONAL CORPORATION
8.10. VEEVA
SYSTEMS INC
9. RESEARCH
METHODOLOGY & SCOPE
9.1. RESEARCH
SCOPE & DELIVERABLES
9.1.1. OBJECTIVES
OF STUDY
9.1.2. SCOPE
OF STUDY
9.2. SOURCES
OF DATA
9.2.1. PRIMARY
DATA SOURCES
9.2.2. SECONDARY
DATA SOURCES
9.3. RESEARCH
METHODOLOGY
9.3.1. EVALUATION
OF PROPOSED MARKET
9.3.2. IDENTIFICATION
OF DATA SOURCES
9.3.3. ASSESSMENT
OF MARKET DETERMINANTS
9.3.4. DATA
COLLECTION
9.3.5. DATA
VALIDATION & ANALYSIS
TABLE 1: NORTH AMERICA
CLINICAL TRIAL MANAGEMENT MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)
TABLE 2: VENDOR SCORECARD
TABLE 3: NORTH AMERICA
CLINICAL TRIAL MANAGEMENT MARKET, BY DEPLOYMENT MODE, 2021-2028 (IN $ MILLION)
TABLE 4: NORTH AMERICA
CLINICAL TRIAL MANAGEMENT MARKET, BY COMPONENT, 2021-2028 (IN $ MILLION)
TABLE 5: NORTH AMERICA
CLINICAL TRIAL MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2028 (IN $ MILLION)
TABLE 6: NORTH AMERICA
CLINICAL TRIAL MANAGEMENT MARKET, BY END-USER, 2021-2028 (IN $ MILLION)
TABLE 7: NORTH AMERICA
CLINICAL TRIAL MANAGEMENT MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)
FIGURE 1: NORTH AMERICA
CLINICAL TRIAL MANAGEMENT MARKET, BY DEPLOYMENT MODE, 2020 & 2028 (IN %)
FIGURE 2: PORTER’S FIVE
FORCES ANALYSIS
FIGURE 3: MARKET
ATTRACTIVENESS INDEX
FIGURE 4: NORTH AMERICA
CLINICAL TRIAL MANAGEMENT MARKET, BY WEB-BASED DEPLOYMENT, 2021-2028 (IN $
MILLION)
FIGURE 5: NORTH AMERICA
CLINICAL TRIAL MANAGEMENT MARKET, BY ON-PREMISE DEPLOYMENT, 2021-2028 (IN $
MILLION)
FIGURE 6: NORTH AMERICA
CLINICAL TRIAL MANAGEMENT MARKET, BY CLOUD-BASED DEPLOYMENT, 2021-2028 (IN $
MILLION)
FIGURE 7: NORTH AMERICA
CLINICAL TRIAL MANAGEMENT MARKET, BY SOFTWARE, 2021-2028 (IN $ MILLION)
FIGURE 8: NORTH AMERICA
CLINICAL TRIAL MANAGEMENT MARKET, BY HARDWARE, 2021-2028 (IN $ MILLION)
FIGURE 9: NORTH AMERICA
CLINICAL TRIAL MANAGEMENT MARKET, BY SERVICES, 2021-2028 (IN $ MILLION)
FIGURE 10: NORTH
AMERICA CLINICAL TRIAL MANAGEMENT MARKET, BY ENTERPRISE-BASED CTM, 2021-2028
(IN $ MILLION)
FIGURE 11: NORTH
AMERICA CLINICAL TRIAL MANAGEMENT MARKET, BY SITE-BASED CTM, 2021-2028 (IN $
MILLION)
FIGURE 12: NORTH
AMERICA CLINICAL TRIAL MANAGEMENT MARKET, BY PHARMACEUTICAL &
BIOPHARMACEUTICAL COMPANIES, 2021-2028 (IN $ MILLION)
FIGURE 13: NORTH
AMERICA CLINICAL TRIAL MANAGEMENT MARKET, BY CLINICAL RESEARCH ORGANIZATIONS,
2021-2028 (IN $ MILLION)
FIGURE 14: NORTH
AMERICA CLINICAL TRIAL MANAGEMENT MARKET, BY HEALTHCARE PROVIDERS, 2021-2028
(IN $ MILLION)
FIGURE 15: NORTH
AMERICA CLINICAL TRIAL MANAGEMENT MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN
%)
FIGURE 16: UNITED STATES
CLINICAL TRIAL MANAGEMENT MARKET 2021-2028 (IN $ MILLION)
FIGURE 17: CANADA
CLINICAL TRIAL MANAGEMENT MARKET 2021-2028 (IN $ MILLION)